Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy.
about
Proteomic dissection of cell type-specific H2AX-interacting protein complex associated with hepatocellular carcinomaCurrent approaches in treatment of triple-negative breast cancerComputer-aided Molecular Design of Compounds Targeting Histone Modifying EnzymesNew approaches of PARP-1 inhibitors in human lung cancer cells and cancer stem-like cells by some selected anthraquinone-derived small moleculesPARP-1 expression and activity in primary human lung cells.Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectivesInhibition of poly (ADP-Ribose) polymerase-1 in telomerase deficient mouse embryonic fibroblasts increases arsenite-induced genome instabilityA new arylbenzofuran derivative functions as an anti-tumour agent by inducing DNA damage and inhibiting PARP activity.A second target of benzamide riboside: dihydrofolate reductaseNew tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors.Detection of somatic BRCA1/2 mutations in ovarian cancer - next-generation sequencing analysis of 100 cases.Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity?Poly(ADP-ribose) polymerase inhibitors as promising cancer therapeutics.Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.Poly (ADP-ribose) polymerase (PARP): rationale, preclinical and clinical evidences of its inhibition as breast cancer treatment.Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model.Therapeutic Targeting of Poly(ADP-Ribose) Polymerase-1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities.MRE11A and SKP2 genes are associated with the increased cytotoxicity induced by the synergistic effects of cisplatin and gemcitabine in bladder cancer cells.High PARP-1 expression is associated with tumor invasion and poor prognosis in gastric cancer.Comparative study of the binding characteristics to and inhibitory potencies towards PARP and in vivo antidiabetogenic potencies of taurine, 3-aminobenzamide and nicotinamide.Inhibition of Poly(ADP-Ribose) Polymerase by Nucleic Acid Metabolite 7-Methylguanine.Ceramide-containing liposomes with doxorubicin: time and cell-dependent effect of C6 and C12 ceramide.Polygodial analog induces apoptosis in LNCaP prostate cancer cells.Poly(ADP-ribose) polymerase-3 overexpression is associated with poor prognosis in patients with breast cancer following chemotherapyRedistribution of the nuclear protein IFI16 into the cytoplasm of ultraviolet B-exposed keratinocytes as a mechanism of autoantigen processing
P2860
Q22001505-FB1C7552-D658-494E-BC8D-537C992257EBQ26801549-8C9CBE2D-246E-4004-8034-910584778674Q28083849-F490D4C8-6445-4F0F-83EB-3FD882FA9E30Q28486776-3DCACCEE-06B0-4056-9EBA-4AA503D2E260Q30318555-A3719B77-1763-43DF-B1A7-33F574D335AAQ30570945-02A36659-05E5-46B3-8A92-D4AD30A4878BQ34009753-747928CE-C99A-4A9B-88FE-7ACBC76578BFQ35681896-501152BD-A17A-47E9-B333-0F5675308C86Q36384346-889ADFF7-853C-4A63-A0D0-344EBC3512B7Q36547381-50EFF385-049C-446A-B3D1-3CE2EF8D2765Q36903256-6BC8AAEB-2795-4FED-9CCC-034101D259FEQ37594776-39FB0C3B-6812-4DB4-8942-2C29E25C9B01Q37727996-759B5919-758E-4374-976B-1D8AC49A90BEQ37774359-23CE345D-9902-4D88-A927-B6F255B5D79AQ37996432-A70E877B-E424-44BC-8A69-F3270C9CA1A7Q38012434-7584286B-207C-4B6A-8447-E81279C67315Q38683171-6CDBACF3-1D67-4A3E-9EA7-51BDAA3281D1Q39013393-392A5620-FD6D-4382-912E-DFE9D3E26882Q40432109-457D0389-0DCD-4E1F-B8B8-2CCBB8F6504BQ41393165-44615D9D-5EE9-466E-9662-346CA002DA08Q42416019-8D872162-F3E3-4BDD-8832-2306C147B553Q46269345-5C075E37-2C00-4DB5-A819-10360A722417Q52639631-FAE0665C-0128-47CF-8622-8F8BEC01C5DBQ57788820-2B399170-14CE-48BB-B046-BA811F262A17Q58482100-2E14CD10-42B0-4B54-8F67-E0568E784F41
P2860
Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy.
@en
type
label
Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy.
@en
prefLabel
Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy.
@en
P2093
P1476
Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy.
@en
P2093
Carlos Alonso
Celia Quevedo
Josefina Castilla
José M Pérez
Manual Soto
Miguel A Fuertes
Victoria Cepeda
P356
10.2174/157489206775246430
P577
2006-01-01T00:00:00Z